RLAY — Relay Therapeutics Inc.

Ownership history in MPM BioImpact LLC  ·  12 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Relay Therapeutics Inc. (RLAY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.24% (2023 Q1)
Avg. % of fund
2.19%
First filed
2023 Q1
Last filed
2025 Q4
Quarters held
12
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 2,232,451 -50,229 -2.2% 2.16% $18.9M $8.46
2025 Q3 UNCHANGED 2,282,680 — 0% 1.95% $11.9M $5.22
2025 Q2 REDUCED 2,282,680 -13,244 -0.6% 1.37% $7.9M $3.46
2025 Q1 ADDED 2,295,924 +27,099 +1.2% 1.03% $6.0M $2.62
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RLAY price (monthly, adj. close)

Other funds also holding RLAY

As of 2025 Q4 — sorted by position size

Commodore Capital LP 3Y 9.57% Casdin Capital, LLC 3Y 7Y 6.83% Foresite Capital Management IV, LLC 3Y 7Y 3.68% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 2.36% Elmind Capital, LP 1.34% Bellevue Group AG 3Y 7Y 1.34% HighVista Strategies LLC 3Y 7Y 1.19% TCG Crossover Management, LLC 3Y 0.9% Kynam Capital Management, LP 3Y 0.77% Alphabet Inc. 3Y 0.51%
← Back to MPM BioImpact LLC Holdings